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Abstract. p53 is a widely known tumor-suppressor gene 
product that plays a key role in apoptotic cell death induced 
by DNA-damaging chemotherapeutic agents. Human glioma 
cells with functional p53 are known to be more resistant to 
γ-radiation. The aim of this study was to investigate whether 
the mutant glioblastoma cells (U87MG) transfected with 
human papilloma virus-type 16 E7 (HPV16 E7) genes were 
capable of increasing sensitivity towards irradiation and 
hypoxia-induced cell death. The pLXSN retroviral vector 
expressed HPV-16E7 genes and was infected into the p53 
mutated U87MG cell line. A specific amplification band of 
HPV16 E7 genes was detected in E7 genes and transfected in 
the U87MG cell line using a reverse transcriptase polymerase 
chain reaction. The experimental groups included the mutant 
glioblastoma cell line (U87MG), empty vector (pLXSN) 
transfected to mutant glioblastoma cell line (U87MG-LXSN), 
and retrovirus carrying HPV16 E7 genes transfected to 
the mutant glioblastoma cell line (U87MG-E7). Hypoxic 
conditions were optimized using LDH assay and the subjects 
were exposed to hypoxia (16 and 20 h) and irradiation (9 h). 
Hoechst-propidium iodide (PI) staining results showed that 
hypoxia and irradiation increased the number of dead cells 
in the U87MG-E7 cells compared to U87MG and U87MG-
LXSN cells. Results of the FACS analysis showed a similar 
pattern and recorded 80.44 and 58.94% of apoptotic cells in 
U87MG-E7 and U87MG cells, respectively. Cell cycle anal-
ysis by FACS revealed that, following irradiation and hypoxia, 
cells showed G2-M arrest. Additionally, the Western blot 
analysis results showed altered expression of E2F-1, Rb and 
p53 in the irradiation- and hypoxia-induced U87MG-E7 cells 
compared to U87MG and U87MG LXSN cells. In conclusion, 
the over-expression of HPV16 E7 genes in U87MG cell lines 
increasd cell apoptosis and E2F1 expression compared to the 
HPV non-infected U87MG cells following irradiation and 
hypoxia. These results indicate that tumor-specific therapies 
that increase sensitivity towards radiation and hypoxic condi-
tions may be beneficial for suppression of cancers.
Introduction
A glioma is a type of tumor that starts in the brain or spine, 
and whose name derives from glial cells. Its most common 
site is the brain and it is divided into four stages according 
to the WHO classification (1). Although grades III and IV 
are malignant, the prognosis for these types of tumors are 
relatively different (2,3). Malignant brain tumors, particularly 
glioblastomas, are notorious for their resistance to therapy (4).
Glioblastomas are known to resist radiotherapy and 
chemotherapy. Besides other intrinsic properties, the presence 
of hypoxia in these tumors may be significant in determining 
resistance to radiation treatment (5-9). However, the under-
lying molecular mechanism(s) of their radioresistance, as well 
as radiation-induced apoptotic death of glioma cells has yet to 
be elucidated.
DNA-damaging agents, used to treat malignant tumors, 
induce tumor cell apoptosis (10). Radiation-induced DNA 
damage and cytotoxicity are crucial in understanding 
tumorigenesis and for optimizing radiation therapy. Increased 
radiosensitivity and constant radiosensitivity have been asso-
ciated with p53 function in various studies as p53 is frequently 
mutated or inactivated in human gliomas.
p53 stimulates transcriptional activation to regulate 
cell-cycle control, DNA repair and synthesis, and apoptosis 
(11,12), and also mediates the apoptotic pathway by inducing 
caspase-3 activation (13). This p53 stabilization was controlled 
by the E2F1 cell cycle-regulated transcription factor (14-16). 
Overexpression of E2F1 in keratinocytes leads to an increased 
expression of CDK7, BRCA1 and p19ARF, which in turn 
increase p53 activity through the mechanisms indicated. 
This leads to a selective increase in the expression of three 
downstream targets of p53, Mdm2, cyclin G and Bax-α, 
thereby predisposing the cells to enter an apoptotic pathway 
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via appropriate external stimuli, such as carcinogen-induced 
DNA damage (17). However, the relationship between p53 
gene expression and cellular radiosensitivity remains to 
be determined (18-24). Previous studies demonstrated the 
response of p53 gene to radiation therapy in glioblastoma cell 
lines, U87 expressing wild-type p53 and U87MG expressing 
mutant-type p53 (25-30).
The human papilloma viruses (HPVs) are small DNA- 
containing viruses that exhibit a specific tropism for epithelial 
cells, and infection with these HPV types leads to a high-risk 
for the development of malignant disease. The most common 
of these high-risk HPV types are HPV-16 and HPV-18, 
shown to encode transforming and immortalizing activities 
in cultured cells (31-35). The early stage expression protein 
E7 in HPV-16 has been ascribed to its ability to bind the 
retinoblastoma (Rb) gene product and leads to stabilization 
of the p53 tumor suppressor protein through E2F1 activa-
tion. Stabilization and accumulation of wild-type p53 usually 
result in either cell growth arrest or apoptosis. The HPV-16 
E7 proteins interfere with several cell cycle checkpoints 
altering the levels of E2F-1, Rb and p53 in response to DNA 
damage (36-39).
In this study, we primarily investigated the effect of 
HPV-16 E7 genes in glioblastomas. Notably, over-expression 
of the HPV-16E7 genes that affect the cell cycle at a specific 
check point should have a more profound effect on tumor 
suppression therapy.
Materials and methods
Cell culture. The human glioma cell line U87MG containing 
the wild-type p53 gene was purchased from the American 
Type Culture Collection (ATCC, Rockville, MD, USA). The 
cells were maintained in Dulbecco's modified Eagle's medium 
(DMEM, Gibco-BRL, Grand Island, NY, USA) supplemented 
with 10% (v/v) fetal bovine serum (FBS) (Gibco-BRL) and 
10 g/ml penicillin/streptomycin (Gibco-BRL) in a humidified 
atmosphere containing 5% CO2 at 37˚C.
Expression of HPV16 E7 genes in glioma cells (U87MG). The 
HPV16 E7 gene was amplified using E7 specific primers (sense, 
5'-GAT GGT CCT GCT GGA CAA GC-3' and antisense, 
5'-GGA TCA GCC ATG GTA GAT TAT GG-3') for 35 cycles, 
programmed as: initial denaturation for 5 min at 95˚C followed 
by 1 min at 95˚C, 1 min at 50˚C, and 1 min 72˚C. Following 
this step, a final extension was carried out at 72˚C for 10 min. 
The retroviral vector pLXSN was used to express the E7 genes 
of HPV-16 containing the neomycin-resistance gene to the 
U87MG cell line with wild-type p53 gene. The construction 
and generation of the retroviruses was described by Halbert 
et al (40). Glioma cells expressing the viral genes were selected 
in 400 µg/ml G418 (Gibco-BRL) for 5 days. Stably prolifer-
ating cells were screened for E7 mRNA expression by reverse 
transcription polymerase chain reaction (RT-PCR).
RT-PCR. Total RNA was isolated and purified with TRIzol 
reagent (Invitrogen, Carlsbad, CA, USA) according to the 
manufacturer's instructions. The obtained RNA was quanti-
tated by measuring the absorbance at 260 nm. Synthesis of 
cDNA from mRNA and the normalization of the samples 
were carried out by RT-PCR. Amplification of E7 cDNA was 
carried out for 35 cycles, programmed as: initial 5 min dena-
turation at 95˚C followed by 1 min at 95˚C, 1 min at 50˚C, 
and 1 min 72˚C. Following this step, a final extension was 
carried out at 72˚C for 10 min. The sequences of the specific 
primers were as follows: sense, 5'-GAT GGT CCT GCT GGA 
CAA GC-3' and antisense, 5'-GGA TCA GCC ATG GTA GAT 
TAT GG-3' for the E7 virus protein. The PCR products were 
separated by electrophoresis in 1.5% agarose gels stained with 
ethidium bromide.
Hypoxia treatment or γ-irradiation. The response of the 
cells to low-oxygen environment and radiation was assessed 
by subjecting the cells to hypoxia and irradiation. In brief, 
cells were incubated in an anaerobic culture chamber (Forma 
Scientific Anaerobic chamber) at 0% oxygen for 16 or 20 h 
followed by 9 h of radiation using Gammacell 3000 Elan.
Measurement of lactate dehydrogenase (LDH) activity. 
Cell death was quantified by assaying LDH release into the 
culture medium. Different time points were selected and the 
percentage of LDH release was determined. The total amount 
of LDH released from 100% cell death, termed ‘full kill’, was 
determined at the end of the experiment by freezing the cells 
at -80˚C followed by rapid thawing. The extent of cell death 
was expressed as a percentage of full kill. The percentage of 
LDH was calculated against the percentage of full kill (41).
Determination of apoptosis and cell cycle. For cell cycle 
analysis U87MG, U87MG-pLXSN and U87MG-E7 cells 
were harvested, washed with phosphate-buffered saline (PBS) 
and fixed in 70% ethanol. Propidium iodide (PI) (50 mg/
ml in PBS, containing 100 mg/ml RNase A) was added for 
5 min. DNA content was analyzed using a FACScan (Becton-
Dickinson, Mountain View, CA, USA). The cell population in 
each cell-cycle phase was determined by CellQuest software 
(Becton-Dickinson Immunocytometry Systems, San Jose, 
CA, USA).
The experimental groups subjected to hypoxia and radia-
tion injury were stained with Hoechst 33258/PI to determine 
the apoptotic cells. Briefly, 2-3 µg/ml Hoechst 33258 dye 
(Sigma, St. Louis, MO, USA) was added to the culture 
medium for 20 min and then the samples were maintained 
at 37˚C for 30 min. PI solution (2-5 µg/ml) was then added 
prior to observation under a fluorescent microscope (Olympus 
Diaphot, Tokyo, Japan) (42). Cell injury was evaluated 
morphologically by counting Hoechst-positive, PI-positive, 
Hoechst-positive, and PI-negative cells as non-viable and 
viable, respectively.
Western blot analysis. The U87MG, U87MG pLXSN and 
U87MG-E7 cells were washed twice with PBS and lysed in 
cold lysis buffer containing protease inhibitor cocktail. The 
cells were incubated at 4˚C for 1 h, and then centrifuged for 
30 min at 12,000 rpm at 4˚C. The protein concentration was 
determined using the BCA protein assay (Pierce, Rockford, 
IL, USA), and soluble protein (30 µg) was resolved by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE). The separated proteins were then electrotrans-
ferred onto nitrocellulose membrane (Millipore, Billerica, 
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MA, USA) using standard procedures. The membranes were 
blocked with 5% dry milk in TBS (10 mM Tris-HCl pH 7.5, 
150 mM sodium chloride) for 3 h and were then incubated with 
primary antibodies for 1 h. The antibodies used were mouse 
monoclonal anti-p53 antibody, (Santa Cruz Biochemistry, 
Santa Cruz, CA, USA), mouse monoclonal anti-pRb antibody 
(Santa Cruz Biochemistry), and rabbit polyclonal anti-E2F-1 
antibody (Santa Cruz Biochemistry). After incubation with 
primary antibodies the membranes were washed with TBS 
solution, and were then incubated with respective secondary 
antibodies: HRP-goat anti-mouse IgG conjugate (Zymed 
Laboratories, San Francisco, CA, USA) and anti-rabbit 
IgG, (Amersham, Piscataway, NJ, USA), using the ECL kit 
according to the manufacturer's instructions (Amersham).
Results
Retroviral infection of human papilloma virus E7 (HPV16 E7) 
genes in glioblastoma cell line (U87MG) induced strong 
endogenous transgene expression. The human papilloma-
virus (7.9 bp, Fig. 1A) is divided into early (E) and late (L) 
stage expression protein regions, containing seven early and 
two late open reading frames (ORFs), and a non-coding URR 
containing the origin of DNA replication and binding sites for 
numerous transcription factors. Primers were designed for the 
detection of HPV16 E7 genes with the sense primer starting 
at 676 bp and the anti-sense primer ending at 875 bp. RT-PCR 
data (Fig. 1B) showed a specific amplification band (200 bp) 
in the HPV16 E7 genes infected to the U87MG cell line 
(Lane 1). However, the retrovirus non-infected U87MG cell 
  A
  B
Figure 2. Hypoxia-induced cell death in human glioma cells was detected by LDH assay. (A) A total of 55% of LDH release was recorded after 24 h of 
hypoxic injury in U87MG cells. The experiment was repeated three times and the result was shown as the mean ± SE, *P<0.01. (B) The U87MG, U87MG-
LXSN and U87MG-E7 cells after hypoxia, hypoxia-irradiation and hypoxia-irradiation-hypoxia were stained with 10 µM of Hoechst 33258/PI for 10 and 
1 min, respectively, to determine the dead cells under a fluorescent microscope (magnification, x200). 
Figure 1. Cloning of human papilloma-virus type 16 (HPV 16) in a U87MG 
cell line. (A) Genomic organization of HPV16 and the cloning site. The HPV 
genome constitutes regions labeled L (late), E (early) and URR (upstream 
regulatory region). Dark gray box of E7 site is used for cloning into the 
retrovirus vector using restriction enzyme digestion. (B) The gels 
were stained with ethidium bromide and images were captured with a 
UV light to confirm the retroviral transfection of the E7 gene expres-
sion in the U87MG cell line. Detection of the transgenic expression 
of E7 genes was performed using E7 gene primers by RT-PCR. M is 
100 bp DNA marker. Lane 1, RT-PCR amplification band of HPV16 E7 
genes (200 bp) in U87MG cells transfected with the retrovirus vector 
(pLXSN containing HPV16 E7 genes). Lane 2, RT-PCR of U87MG cells 
infected with pLXSN without E7 gene insert. Lane 3, U87MG cells. 
Lane 4, negative control.
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line and the pLXSN infected U87MG cell line did not show 
any endogenous expression of HPV16 E7 genes (Lanes 2 
and 3). M is the 100 bp DNA ladder marker and Lane 4 is the 
negative control.
Radiation- and hypoxia-induced apoptosis in U87MG cells 
expressing E7 genes. LDH assay was performed to optimize 
the condition for hypoxia in the U87 human glioma cell line at 
different time periods. Approximately 20 and 53.3% of LDH 
release was recorded in U87MG cells subjected to hypoxia at 
20 and 24 h, respectively (Fig. 2A). Based on the LDH data, 
hypoxia of 16 and 20 h were adapted for Hoechst/PI and 
FACS analysis. Hoechst/PI staining showed an increase in 
the apoptotic cell death and marked morphological changes in 
the U87MG-E7 cell line compared to the E7 non-transfected 
experimental groups (U87MG and U87MG-LXSN) subjected 
to hypoxia and irradiation (Fig. 2B). Results of the FACS anal-
ysis revealed that U87MG cells expressing HPV16 E7 genes are 
more sensitive to radiation and hypoxia (Fig. 3). Four hours after 
irradiation, the E7-expressing U87MG cells, under hypoxic 
conditions, recorded 80.44% of apoptotic cells compared with 
U87MG cells (58.94%). The U87MG-E7 cell line was found to 
be more sensitive to the radiation under hypoxic conditions.
p53-independent G0-G1 cell cycle arrest in U87MG cells 
expressing HPV16 E7 genes subjected to hypoxia and 
radiation. DNA-damaging agents, such as hypoxia or ionizing 
radiation, induce a nuclear accumulation of the p53 tumor 
suppressor protein. However, most tumor cells lack functional 
p53 and would not arrest in G1. Thus, the greatest cell cycle 
perturbation of an irradiated tumor cell was detected in the 
delay in the transition from the G2 to M phase. A prolonged 
arrest in G2-M after radiation has been associated with 
increased radioresistance in the human cell line. Under 
hypoxic conditions, the G0-G1 arrest in U87MG glioblas-
toma cells expressing wild-type p53 was determined using 
CellQuest software (Becton-Dickinson Immunocytometry 
Systems) and the induction of the E2F-1 and Rb proteins of 
these cells was detected using Western blotting. The U87MG 
cells after irradiation under hypoxic conditions showed G2-M 
arrest due to an increased expression of p53 and decreased cell 
levels of Rb and E2F-1 proteins (Fig. 4A,B). In the HPV16 E7 
Figure 3. Effect of HPV16 E7 transgene expression in U87MG cells subjected to hypoxia and radiation. The experimental groups (U87MG, U87MGLXSN 
and U87MG E7) were exposed to hypoxia (16  and 20 h) and irradiation (9 h) stained with PI. FACS analysis was performed to analyze the cell cycle. Values 
are the percentage of apoptotic cells using CellQuest software. Results are shown as the average of three different experiments; mean ± SE. *P<0.01, signifi-
cant difference between the data pertaining to U87MG and the remaining cell lines. 
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transduced U87MG cell line, however, no cells were trapped 
in the G2-M phase, indicating that E7 genes induce apoptosis 
following hypoxia and irradiation (Fig. 4C). Moreover, the 
cell levels of E2F-1, Rb were markedly decreased following 
hypoxia and irradiation with an increase in p53 expression 
demonstrating that E7 genes induced apoptosis independently 
of p53 (Fig. 4D). Cell cycle analysis by FACS showed G2-M 
phase arrest and the Western blotting results showed an 
increase in the E2F-1 expression in the U87MG-E7 cell line 
compared with U87MG and U87MG-LXSN, whereas p53 
expression was not significantly altered.
Discussion
Grade III and IV gliomas are the most malignant brain tumors 
encountered in adults and the most frequent solid neoplasms 
found in children (2,3). In a normal cell, p53-dependent 
cell-cycle arrest allows enough time for the DNA damaged 
by agents to be repaired (11). This is often achieved by a 
disruption of the p53 pathway in the glioblastoma (3,43,44). 
At least 25% of glioblastomas have mutations or deletions of 
the p53 gene itself, and another 5-12% have amplifications 
of the locus on chromosome 12, which encodes Mdm2, and 
which promotes degradation of p53 (2). These tumors are 
highly resistant to conventional treatments such as surgery, 
radiotherapy and chemotherapy. Studies exploring other 
therapeutic potentials for the treatment of tumors, including 
gene therapy, are currently underway (27). In their study, 
Gomez-Manzano et al demonstrated that adenovirus- 
mediated p53 gene delivery in glioma cell lines increased 
apoptosis (45). However, glioma cells with wild-type p53 
did not undergo apoptosis, but showed a slower growth rate, 
becoming sensitive to radiation treatment (24,29,46), indi-
cating that the function of p53 is regulated by cell conditions 
and that p53 alone cannot trigger the apoptotic signaling 
pathway.
Based on the available evidence, apoptotic cell death in 
the tumors could be p53-independent. Therefore, we aimed 
to investigate whether the p53 mutated glioblastoma cell line 
(U87MG) transfected with HPV16 E7 proteins was capable of 
triggering the apoptotic signaling pathway regardless of p53 
expression. The cloning of HPV16 E7 genes and their transfec-
tion into the p53 mutated glioblastoma cell line (U87MG-E7) 
was performed using the retrovirus expression system. The 
specific amplicons confirming the integration of the HPV16 E7 
genes was detected in U87MG-E7 cells using RT-PCR 
reaction (Fig. 1). The HPV16 E7 protein deregulates the cell 
cycle through interactions with a variety of proteins involved 
in cell cycle control and transcriptional regulation (36). The 
HPV16 E7 protein binds to Rb and causes release of the 
transcription factor E2F-1, which in turn, stimulates cell cycle 
progression or apoptosis depending on cell cycle conditions 
(47,48). Mice expressing the human papilloma virus E7 protein 
in photoreceptors were generated (36). Notably, E7 mice did 
not develop retinal tumors but showed apoptosis instead. E7 
mice crossed with p53-knockout mice tend to develop tumors 
Figure 4. Hypoxia and irradiation induced cellular alterations in U87MG cells before (A and B) and after (C and D) HPV16 E7 gene transfection. (A) FACS 
analysis of hypoxia and irradiation induced apoptosis in the U87MG cell line. Distributions of DNA content in the cell cycle were shown as a representative of 
three experiments. (B) Expression of Rb, E2F-1 and p53 proteins in the U87MG cell line by Western blotting. (C) FACS analysis of U87MG-E7 cells exposed 
to hypoxia and irradiation. Distributions of DNA content were shown as a representative of three experiments. (D) Expression of Rb, E2F-1 and p53 expression 
in U87MG-E7 cells by Western blotting. 
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(49). Thus, the status of p53 may determine cell fate. The stabi-
lization of p53 and the concomitant destabilization of pRB 
that are detected in E7-expressing cells are reminiscent of the 
effects elicited once DNA damage or a cellular stress signal 
has been initiated in a cell (36). 
The present study suggests that HPV16 E7 genes increased 
radiosensitivity in a wild-type p53 glioma cell under hypoxic 
condition hypothesizing that ‘high-risk HPV16 E7 genes 
stimulate apoptosis’, which was confirmed by Hoechst/
PI staining and cell cycle analysis (Figs. 2 and 3). In the 
HPV16 E7 genes non-transfected U87MG cells, the duration 
of the G2-M arrest was associated with p53 status. However, 
U87MG cells expressing HPV16 E7 genes, underwent G0-G1 
arrest and a large percentage of apoptosis was associated with 
the stabilization of the p53 expression. On the other hand, it 
should be noted that the U87MG cells used in this study are 
resistant to treatment with irradiation and hypoxia, but a large 
percentage of apoptotic cells were detected in HPV16 E7 genes 
transfected to the U87MG cell line. HPV16 E7 genes trans-
fected to the U87MG cell line inhibited the pRB pathway. An 
increase in wild type-p53 protein expression after irradiation 
provided an additional mechanism for glioma cells to increase 
radiosensitivity (Fig. 4). Following the FACS analysis, the 
results indicate that transfection of E7 genes overcomes the 
resistance mechanism of glioma cells after irradiation under 
hypoxic conditions by the arrest of the G0-G1 phase in the 
cell cycle. HPV16 E7 protein binds to Rb and causes release 
of the transcription factor E2F-1, which in turn, stimulates 
cell cycle progression or apoptosis depending on cell cycle 
conditions. HPV16 E7 induced increased levels of p53 expres-
sion after irradiation and p53 is essentially required for the 
G1 checkpoint after irradiation. Evidence suggests that p53 
plays a role in the G2 and mitotic checkpoints. Therefore, we 
investigated the effects of transgene therapy in glioblastoma 
with HPV16 E7 genes and the relationship between HPV16 E7 
gene expression and radiosensitivity in the U87MG cell line by 
evaluating the degree of cell death and apoptosis. The results 
of the present study suggest that HPV16 E7 genes increased 
radiosensitivity in U87MG-E7 cells under hypoxic condition. 
In U87MG cells, the duration of the G2-M arrest was asso-
ciated with p53 status, and p53-wild type cells underwent 
prolonged arrest associated with the elevation of p53 levels. 
On the other hand, U87MG cells expressing HPV16 E7 genes 
underwent G0-G1 arrest and a large percentage of apoptosis 
was associated with the stabilization of p53 protein expression. 
The transfer of HPV16 E7 genes to correct the genetic defect 
appears to be feasible. Therefore, transduction of E7 genes may 
provide the possibility to overcome the resistance mechanism 
of glioma cells after irradiation under hypoxia through the 
arrest of G0-G1 cell cycle with the stabilization of p53.
In conclusion, HPV16 E7 over-expressed U87MG cells 
resulted in the stabilized expression of p53 under hypoxia condi-
tions. Therefore, this approach may provide insight into the 
development of γ-radiation therapy for malignant brain tumors.
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